MedPath

JAKAVI 5 MG COMPRIMIDOS

JAKAVI 5 MG COMPRIMIDOS

Commercialized
Register Number

112773005

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jun 10, 2013

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number112773005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RUXOLITINIBActive
Quantity: 5 mg
Name: RUXOLITINIB

ATC CLASSIFICATION (3)

L01E
L01EJ
L01EJ01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.